Canada is a wealthy country with the fastest growing population among the G7 nations. At an estimated US$ 12 billion in 2024, Canada is the eight largest market globally for medical devices. Revenue in this market is expected to grow at annual rate of 6% from 2024 to 2028. Furthermore, the country is experiencing a surge in demand for telemedicine solutions, spurred by the country’s vast land area, the remote healthcare needs and the ageing population. This momentum creates sizeable business opportunities for Swiss companies in medtech and digital health sector.
S-GE and the Swiss Business Hub Canada are providing an overview of the Canadian medtech and digital health market, as well as its distinctions from the U.S. market. The invited speakers are covering the following elements: the regulatory approval process, the eligibility for health insurance reimbursement, funding opportunities (public and private) for Swiss healthcare startups in Canada, and collaboration opportunities with Canadian companies and organizations.
